Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

OL3 EPR regular production of electricity starts in February 2022

Teollisuuden Voima Oyj (TVO) has received an updated re-baseline schedule on the commissioning of the OL3 EPR plant unit from the supplier Areva-Siemens consortium. According to the schedule fuel will be loaded into the reactor in March 2021, the unit will be connected to the grid in October of the same year, and regular electricity production starts in February 2022.Issues that have caused delays in the project schedule are slowly progressing system testing, technical problems that have been identified in tests, and the increase in the amount of maintenance work caused by project delay.

NENT Group expands UFC coverage to Iceland

· Viaplay now home to UFC in all five Nordic countries · More than 8% of Icelandic households already signed up to a Viaplay package · NENT Group has rights to show more than 50,000 hours of the world’s best live sporting action every year on its streaming services and TV channels Nordic Entertainment Group (NENT Group), the Nordic region’s leading streaming company, has expanded its Nordic UFC rights to Iceland until the end of 2021. Starting this weekend, UFC fans in Iceland can follow all the high-impact action from the world’s premier mixed martial arts (MMA) organisation,

Ellevio AB Half Year Report January-June 2020

Key financials · The company welcomed circa 3,000 new customers during the first six months of the year, reaching approximately 965,000 customers at the end of the period · Net sales amounted to SEK 3,455 million (3,662) · Distributed electricity amounted to a total of 13.7 TWh (13.9) · Operating profit amounted to SEK 859 million (1,161) · Free cash flow totalled SEK 531 million (1,346) · Capital expenditure, amounted to 1,391 SEK million (1,266). The report comments on important aspects of the operations during the period, including the implications of the covid-19

SynAct Pharma Initiates RESOVIR: Scientific and clinical Collaboration to Explore AP1189 in Viral Infections

SynAct Pharma AB ("SynAct Pharma") hereby announces that the company together with Prof Mauro Teixeira, MD, PhD, Universidade Federal de Minas, Belo Horizonte, Brazil and Prof Mauro Perretti, PhD William Heavy Research Institute, Barts and the London School of Medicine, Queen Mary University, London, UK has established a scientific and clinical collaboration, RESOVIR (resolution in viral inflammation), aimed to investigate pharmacological promotion of inflammatory resolution as a novel approach to control viral infections. The first step of the collaboration will be to run an exploratory

Interim report, January - June 2020

Second quarter, April - June 2020 · Net Sales amounted to SEK 454.5 m (440.8), an increase of 3.1%. · EBITDA before items affecting comparability amounted to SEK 60.7 m (57.0), an increase of 6.4%. The EBITDA margin before items affecting comparability amounted to 13.4% (12.9%). · EBITDA amounted to SEK 56.6 m (53.1), an increase of 6.6%. The EBITDA margin amounted to 12.5% (12.0%). · Operating profit (EBIT) amounted to SEK 32.7 m (32.0), an increase of 2.0%. The operating margin amounted to 7.2% (7.3%). · Net profit for the quarter amounted to SEK 15.7 m (15.4), an

Fabege granted a land allocation permit at Sveaplan by the City of Stockholm

The Land Development Board (Exploateringsnämnden) decided at its meeting on 27 August 2020 to grant Fabege a land allocation permit at Sveaplan. A prerequisite for the creation of the development right, covering about 9,000 square metres, is that Sveaplan is redeveloped in accordance with the city’s plans for Östra Hagastaden.Fabege owns the well-known Wenner-Gren Center building and the three nearest buildings on Sveavägen. This allows a holistic perspective and co-utilisation of facilities by people using or working in the area. · “It is not often that newbuild opportunities arise

Registration Details for Immunovia’s Second Webinar in the Series on IMMray™ PanCan-d: Commercial Test Model Study & Update on Launch Activities

LUND, SWEDEN – Immunovia AB (publ) (“Immunovia”), today announced that the company will be hosting the second webinar in the series on Immunovia’s IMMray™ PanCan-d. This second webinar will cover the results of the Commercial Test Model Study (link to pr ) and updates on the launch activities. Event Details: Immunovia’s IMMray™ PanCan-d Webinar Series Webinar No. 2: Commercial Test Model Study &

Interim Report 2020-01-01 – 2020-06-30

The Board and Chief Executive Officer of Cereno Scientific AB here with present the Interim Report for the second quarter 2020. Summary of the Interim Report Cereno Scientific Group  Six months (1 January 2020 – 30 June 2020) · Net Sales were 0 SEK. · Loss after financial items was SEK -7 774 588. · Loss per share was SEK -0.19 before dilution and SEK -0,18after dilution*. · The equity/assets ratio was 94,9 %. Second quarter (1 April 2020 – 30 June 2020) · Net Sales were 0 SEK. · Loss after financial items was SEK -4 021 921. · Loss per share was SEK -

Proposal from the Nomination Committee to the Extraordinary General Meeting in Otello Corporation ASA to be held on 4 September 2020

STOCK EXCHANGE ANNOUNCEMENT   Se vedlagte fil for noe informasjon på norsk. (Oslo, Norway, 28 August 2020) On 14 August 2020, Otello Corporation ASA (“Otello”) announced that an extraordinary general meeting would be held on 4 September 2020 at the request Otello’s largest shareholder, Sand Grove Capital Management LLP (“Sand Grove”). Sand Grove has proposed significant changes to the board by replacing chairman André Christiansen and board member Birgit Midtbust with two new board members nominated by Sand Grove, Randel Freeman and Kathryn Baker. This is despite the fact that

Flowscape wins order for seven offices in the UK

A British customer has selected Flowscape Room and Desk Booking solution for seven offices in the UK.  Desk booking is an important part of the customers strategy for safe and controlled return to the office. The order value in the first year is 350,000 SEK and thereafter 175,000 SEK annually.“Our business in the UK is developing very positively and there is a great demand for digital solutions supporting and manage a safe return to the office. We are very happy that our new Covid-19 solution is so popular. This large installation has additional potential when the customer decides to open

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

Announcement no. 29 - 28 August 2020 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, Motortramp A/S continuously sells shares pro rata and the market is to be informed accordingly – see the attached file. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information: Martin Badsted, CFO, tel.: +45 3315 0451Anne-Louise Dam-Rasmussen, Head of Communications, tel.: +45 3273 0624

Interim Report 1 January to 30 June 2020

Summary of the interim reportFirst Half Year (1 January to 30 June 2020) · Operating revenue KSEK 0 (0) · Income after financial items KSEK -24 370 (-13 412) · Earnings per share -0,50 (-0,36) · Cash and cash equivalents as of June 30th KSEK 40 630 (23 872) · Equity ratio as of June 30th 88,3 (90,3) % Second quarter (1 April to 30 June 2020) · Operating revenue KSEK 0 (0) · Income after financial items KSEK -14 187 (-6 655) · Earnings per share -0,29 (-0,18) Significant events during the second quarter of 2020 · Dr Tara Heitner appointed new CEO ·

Q4  Year-end Report July 2019 – June 2020

Opening remarks The fiscal year 2019/2020 of Hamlet Pharma AB has been very successful. Positive results of our first double blind, placebo controlled clinical study were announced and we conclude that Alpha1H treatment shows efficacy in patients with bladder cancer. The patients did not develop drug-related side effects confirming the safety of Alpha1H. The results define Alpha1H as a drug candidate with significant potential in bladder cancer and other cancer indications.Significant research advances form the basis for continued clinical trials.  Based on significant therapeutic

Investment in nickel expansion at Boliden Harjavalta

Boliden invests EUR 40 m in an expansion of its nickel operations at Boliden Harjavalta. The investment will mainly be implemented in 2021.The expansion investment in the nickel line at Harjavalta means that the feed capacity will increase from 310 to 370 ktonnes of raw material per year. The expansion consists of a new concentrate dryer, increased capacity in the electric smelting furnace and granulation, as well as automated tapping of molten metal. “We are now continuing on our nickel strategy that began in 2015. The investment strengthens our productivity and competitiveness while

Interim report January – June 2020

Press release: Uppsala, August 28, 2020. Pharmacolog i Uppsala AB’s (publ) interim report for the period January – June is now available on the company’s webbsite http://www.pharmacolog.com (Swedish only)Andra kvartalet 1 april 2020 – 30 juni 2020 · Bolagets nettoomsättning för perioden uppgick till 357 (1 749) Tkr. · Rörelseresultatet för perioden uppgick till -2 421 (-3 670) Tkr. · Nettoresultat per aktie före och efter utspädning var för perioden -0,25 (-0,50) kr. Första halvåret 1 januari 2020 – 30 juni 2020 · Bolagets nettoomsättning för perioden uppgick till 794 (2

XMReality adds two more companies within Coesia Group to the customer portfolio

XMReality AB has signed contracts with two additional companies within the Coesia Group during August for the usage of XMReality Remote Guidance[TM]. Coesia Group, a global packaging group, has a framework agreement in place with XMReality AB since 2018. This to facilitate for the 21 Coesia companies to sign contracts for the use of XMReality Remote Guidance. Nine of these companies are today customers to XMReality AB.Coesia Group are represented in 35 countries with 84 production sites and XMReality Remote Guidance is used within several areas of their operations. It’s used for support and

Collector informs that the Swedish Financial Supervisory Authority has informed that the assignment of the appointed auditor has been completed and that the case has been closed

The Swedish Financial Supervisory Authority ("SFSA") (Sw. Finansinspektionen) informed Collector Bank AB on 12 February 2020 that the SFSA has, as part of its supervision, appointed an auditor to perform an audit of Collector Bank AB on the SFSA's behalf. The appointment is a result of Collector's announcement on 21 January 2020 of, among other, an extra provisioning for credit losses and that the bank's own funds temporarily fell below the applicable capital buffer requirement.The SFSA has informed Collector that the assignment of the appointed auditor has been completed and that the

Evolution Gaming and BetMGM Sign Agreement for US Market

Evolution Gaming, leading provider of Live Casino solutions, has announced that it has signed a US-wide agreement with BetMGM, the joint venture between MGM Resorts International and GVC Holdings. The agreement will see Evolution power Live Casino services for BetMGM’s brands across the US.Initially the agreement will result in a number of Evolution’s live table games, as well as game show-style games, being made available to customers of BetMGM, and sister brands Borgata Online and Party Casino, from Evolution’s Live Casino studio in New Jersey. The agreement will extend the existing live

SpectrumOne announces today the acquisition of the data company Å-data Infosystem AB

SpectrumOne announces today the acquisition of the data company Å-data Infosystem AB, a company with a strong positive cashflow and that has made profit every year the last decade. The purchase price is SEK 10,000,000 and is paid via shares in SpectrumOne AB, with no additional share issue to current shareholders. Closing is expected to take place on September 1, 2020. In the transaction is included accumulated profits from earlier years and assuming a normalized level of net working capital. The purchase price gives an EBITDA multiple of 3 based on Ådata Infosystems AB:s profit of 2019.

EAB Group Plc publishes its updated Remuneration Policy for Governing Bodies

EAB Group Plc, Stock Exchange Release, 28 August 2020, 9:20 a.m. (EET) EAB Group Plc publishes its updated Remuneration Policy for Governing Bodies EAB Group Plc publishes an updated Remuneration Policy for Governing Bodies, which will be discussed at the Annual General Meeting convened today and hold on 22 September 2020. The Remuneration Policy for Governing Bodies published on 13 March 2020 has not been discussed at the Annual General Meeting as the company’s Annual General Meeting was cancelled in the spring 2020. In the updated Remuneration Policy now announced, flexibility

Notice to EAB Group Plc’s Annual General Meeting

EAB Group Plc, Stock Exchange Release, 28 August 2020, 9:20 a.m. (EET) Notice to EAB Group Plc’s Annual General Meeting EAB Group Plc’s shareholders are invited to the Annual General Meeting to be held on Tuesday 22 September 2020 at 10.00 EET at the company’s premises at Kluuvikatu 3, 3rd floor, Helsinki. The reception of participants enrolled to the meeting will begin at 09.30 EET. ITEMS ON THE AGENDA OF THE ANNUAL GENERAL MEETING At the Annual General Meeting the following matters will be considered: 1. Opening of the meeting 2. Calling the meeting to order 3.

Outstanding H1 for LeadDesk with over 27% growth

LeadDesk Oyj Press release 28/8/2020 9.05 amLeadDesk Oyj Half Year Financial Statement 1/1–30/6/2020 Figures in parenthesis refer to the equivalent period in the previous year, unless otherwise stated.  This document is an unofficial translation of LeadDesk’s unaudited half year financial statement. In case the document differs from the original, the Finnish version prevails. January–June 2020 Highlights ·Revenue EUR 6,211 (6,122) thousand, growth 1.4% · Comparable adjusted revenue EUR 6,211 (5,508*) thousand, growth 22.8% · Comparable adjusted annual recurring billing

Interim report for the period 1 January – 30 June 2020

Second quarter of 2020 Numbers in parentheses refers to outcomes during the corresponding period of the previous year. · Revenues of SEK 0 million (0). · Other operating income of SEK 0.4 million (0.2) mainly pertaining to grants. · Operating costs decreased to SEK 0.8 million (1.2). Administrative expenses decreased to SEK 2.2 million (2.5). The expenses were reduced by a one-off item by SEK 0.8 million, pertaining to an IPO-cost item that was settled at a lower amount than reserved for. · Profit (loss) for the period amounted to SEK -2.8 million (-3.7). · Earnings per

There are no items matching the current filter
There are no more items matching the current filter
Back to top